• Pediatrics
    Distinguished Professor of Pediatrics and Clinical and Translational Medicine; University of Pittsburgh School of Medicine
    Distinguished Professor of Pediatrics and Clinical and Translational Medicine; University of Pittsburgh School of Medicine

    Dr. Hoberman graduated from medical school and general pediatrics residency in Buenos Aires, Argentina. He completed a General Academic Pediatrics fellowship at Children’s Hospital of Pittsburgh and joined the faculty at the University of Pittsburgh. He currently heads the Division of General Academic Pediatrics, is the Vice Chair for Clinical Research, and has been established as the Jack L. Paradise Endowed Professor of Pediatric Research in honor of his research mentor. In the area of AOM, Dr. Hoberman has contributed studies to enhance prevention, diagnosis and treatment of this frequently occurring condition. In a study published in JAMA, Dr. Hoberman evaluated the efficacy of influenza vaccine in preventing AOM. He published a series of studies in the NEJM sponsored by the National Institute of Allergy and Infectious Diseases evaluating the efficacy of and adequate duration of antimicrobial therapy in young children with AOM. The study he is currently reporting in the NEJM was sponsored by the National Institute of Deafness and Other Communication Disorders and evaluated the efficacy of tympanostomy tubes in children with recurrent AOM. 

      In the area of UTI, Dr. Hoberman evaluated prevalence, diagnosis, treatment and follow-up imaging in children. He published in the NEJM a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored study evaluating the efficacy of antimicrobial prophylaxis in children with vesicoureteral reflux, and received the Clinical Research Forum Top 10 Clinical Research Achievement Award of 2015 for this publication. The Pittsburgh research team recently completed two NIH-sponsored UTI clinical trials: (1) a collaboration with the University of Pennsylvania evaluating a short-course therapy for UTI in children, and (2) led by his colleague Dr. Nader Shaikh, a study evaluating corticosteroids in preventing renal scars in children with febrile UTI.

       The quality and influence of Dr. Hoberman’s research is evident from the journals in which they are published, including the NEJMJAMAJAMA Pediatrics and Pediatrics. He has served on NIH special emphasis panels, FDA and NIH strategic planning workgroups, American Academy of Pediatrics guideline committees, and as a member of the Clinical Translational Science Award Child Health Oversight Committee. His research has fostered the careers of many others through his roles in fellowship training, as the chief of a large division of General Academic Pediatrics--the recipient of the 2009 Academic Pediatric Association Outstanding Teaching Award, and in his many other collaborations. In 2014, Dr. Hoberman also received the Academic Pediatric Association Research Award that acknowledges the contribution of an individual in advancing pediatric knowledge through excellence in research, characterized by originality, creativity and methodological soundness. Dr. Hoberman also has administrative responsibilities as the President of UPMC Children’s Community Pediatrics, the largest primary care pediatrics organization in western PA with 58 offices including Express Care locations and over 800,000 yearly visits.

  • Dr. Nader Shaikh is a tenured professor of pediatrics and translational medicine at the Children’s Hospital of Pittsburgh in the Division of General Academic Pediatrics. His research focuses on the common pediatric infections including acute otitis media, acute sinusitis, urinary tract infections and COVID. Dr. Shaikh has authored or co-authored more than 100 peer-reviewed publications and has been continuously funded by the National Institute of Health (NIH) since 2006. He is currently the Principal Investigator on one RO1 and two UO1 studies. Dr. Shaikh has served as a panelist on the American Academy of Pediatrics Acute Sinusitis Guideline Committee and serves regularly as a reviewer for NIH study sections. 

  • Dr. Jack L. Paradise is a professor emeritus of pediatrics at the University of Pittsburgh School of Medicine.  After completing pediatric training, he helped found, and practiced for 19 years in a union-sponsored group-practice program in Appalachia, where he became interested in then-unsettled clinical issues regarding common pediatric problems. In 1970 he joined the University of Pittsburgh faculty, serving for 20 years as chief of the outpatient division at Children’s Hospital of Pittsburgh and as co-director of the combined Hospital-University fellowship training program in ambulatory and community pediatrics.  He retired officially from the faculty in 2005, but has continued to participate remotely in some of the division’s ongoing clinical research activities.

    Dr. Paradise’s research efforts over five decades have been directed at understanding and managing common diseases and disorders of the upper respiratory tract in children, involving in particular the tonsils, adenoids, and middle ear.  From 1973 to 1990 he led a series of NIH-supported studies in Pittsburgh of indications for tonsillectomy and adenoidectomy, findings of which have served as the basis in part for current official guidelines for tonsillectomy. From 1991 to 2005, he led a prospective, NIH-supported randomized clinical trial that tested then-prevalent assumptions that prolonged periods of early-life otitis media could result in various long-term impairments of children’s speech, language, and cognitive development. Additionally, he led or collaborated in other studies mainly involving the diagnosis and management of acute and chronic otitis media.  Dr. Paradise has also served as consultant or advisor for a number of national and international governmental and non-governmental research panels and study groups. He is author or co-author of over 200 peer-reviewed articles, reviews, chapters, and abstracts, and has delivered over 300 lectures for regional, national, and international professional groups.


    Among other research and teaching awards, Dr. Paradise received the 1994 Ambulatory Pediatric Association  (now Academic Pediatric Association) Research Award, and was named 1999 Pennsylvania Pediatrician of the Year by the Pennsylvania chapter of the American Academy of Pediatrics.  



    • Pediatric Otolaryngology
    • Attending Physician, Professor (with tenure) of Surgery and Pediatrics at Children's National Medical Center

    Dr. Preciado is a Professor with tenure at Children’s National Health System and George Washington University.  After completing medical school and otolaryngology residency at the University of Minnesota, he did a two-year pediatric otolaryngology fellowship at Cincinnati Children’s Hospital.  Currently, he serves as Vice-Chief of the Division of Pediatric Otolaryngology as well as Program Director of the ACGME accredited pediatric otolaryngology fellowship at Children’s National. His clinical practice is mainly focused on pediatric airway reconstruction, childhood hearing loss/cochlear implants, and velopharyngeal insufficiency. He has authored over 125 peer-reviewed manuscripts, 20 book chapters and 3 edited books. Dr. Preciado runs an otitis media translational research program which has been funded through numerous extramural awards including several NIH grants. He serves as current a member of the American Board of Otolaryngology Complex Pediatric Otolaryngology Steering Committee and is current President of the American Society of Pediatric Otolaryngology (2020-2021) and the International Society for Otitis Media (2019-2023).



Powered by Medstro